XML 58 R40.htm IDEA: XBRL DOCUMENT
v3.23.2

Share-Based Compensation (Tables) | 12 Months Ended
--- | ---
Jun. 30, 2023
Share-Based Payment Arrangement, Noncash Expense [Abstract] |
Disclosure of Share-based Compensation Arrangements by Share-based Payment Award |
| Fiscal Year Ended June 30,
| 2023 |  | 2022 |  | 2021
| (in thousands)
Share-based compensation related to: |  |  |  |  |
Equity classified stock options | $ | 1,426 |  |  | $ | 1,848 |  |  | $ | 1,332 |
Equity classified restricted stock | 9,793 |  |  | 9,815 |  |  | 6,707 |
Total share-based compensation | $ | 11,219 |  |  | $ | 11,663 |  |  | $ | 8,039 |
Weighted Average Assumptions for the Options Granted During the Following Fiscal Years | The Company used the following weighted-average assumptions for the options granted in fiscal year ended June 30, 2021:
| Fiscal Year Ended June 30,
| 2021 |  |
Expected term | 5 years |  |
Expected volatility | 42.78% |  |
Risk-free interest rate | 0.36% |  |
Dividend yield | 0.00% |  |
Weighted-average fair value per option | $9.01 |  |
Stock Option Plans | A summary of activity under our stock option plans is presented below:
| Fiscal Year Ended June 30, 2023
| Options |  | Weighted- Average Exercise Price |  | Weighted- Average Remaining Contractual Life |  | Aggregate Intrinsic Value
Outstanding, beginning of year | 1,123,099 |  |  | $ | 32.23 |  |  |  |  |
Granted during the period | — |  |  | — |  |  |  |  |
Exercised during the period | (36,435) |  |  | 25.00 |  |  |  |  |
Canceled, forfeited, or expired during the period | (59,993) |  |  | 27.70 |  |  |  |  |
Outstanding, end of year | 1,026,671 |  |  | 32.76 |  |  | 4.57 |  | $ | 2,113,985 |
Vested and expected to vest at June 30, 2023 | 1,026,460 |  |  | 32.76 |  |  | 4.57 |  | $ | 2,112,871 |
Exercisable, end of year | 855,834 |  |  | $ | 34.28 |  |  | 4.01 |  | $ | — |
Unvested Shares | A summary of the status of the Company’s shares subject to unvested options is presented below:
| Fiscal Year Ended June 30, 2023
| Options |  | Weighted Average Exercise Price |  | Weighted Average Grant Date Fair Value
Unvested, beginning of year | 384,638 |  |  | $ | 25.16 |  |  | $ | 9.08 |
Granted | — |  |  | — |  |  | — |
Vested | (171,926) |  |  | 25.11 |  |  | 9.06 |
Canceled or forfeited | (41,875) |  |  | 25.51 |  |  | 9.30 |
Unvested, end of year | 170,837 |  |  | $ | 25.12 |  |  | $ | 9.06 |
Stock Options Outstanding | The following table summarizes information about stock options outstanding and exercisable as of June 30, 2023:
|  | Options Outstanding |  | Options Exercisable
Range of Exercise Prices |  | Shares Outstanding |  | Weighted Average Remaining Contractual Life |  | Weighted Average Exercise Price |  | Number Exercisable |  | Weighted Average Exercise Price
$22.27 - $26.38 |  | 363,233 |  |  | 7.38 |  | 24.53 |  |  | 231,673 |  |  | 24.55 |
$26.38 - $30.49 |  | 119,021 |  |  | 7.40 |  | 27.14 |  |  | 79,744 |  |  | 27.14 |
$30.49 - $34.60 |  | 57,799 |  |  | 4.44 |  | 34.35 |  |  | 57,799 |  |  | 34.35 |
$34.60 - $38.71 |  | 207,169 |  |  | 2.83 |  | 37.71 |  |  | 207,169 |  |  | 37.71 |
$38.71 - $42.82 |  | 279,449 |  |  | 1.02 |  | 41.83 |  |  | 279,449 |  |  | 41.83 |
|  | 1,026,671 |  |  | 4.57 |  | $ | 32.76 |  |  | 855,834 |  |  | $ | 34.28 |
Restricted Stock Outstanding | During the fiscal year ended June 30, 2023, the Company granted 518,987 shares of restricted stock to employees and non-employee directors, all of which were issued in the form of RSUs:
| Fiscal Year Ended June 30, 2023
| Shares granted |  | Date granted |  | Grant date fair value |  | Vesting period
Employees |  |  |  |  |  |  |
Certain employees based on performance | 346,059 |  |  | August 26, 2022 |  | $ | 28.66 |  |  | Annually over 4 years
Certain employees based on performance | 58,323 |  |  | August 26, 2022 |  | $ | 28.66 |  |  | Annually over 3 years
Certain employees based on performance | 58,323 |  |  | August 26, 2022 |  | $ | 27.92 |  |  | Annually over 3 years
Certain employees based on performance | 815 |  |  | December 1, 2022 |  | $ | 30.70 |  |  | Annually over 4 years
Certain employees based on hire | 13,067 |  |  | June 1, 2023 |  | $ | 28.70 |  |  | Annually over 4 years
Non-Employee Directors |  |  |  |  |  |  |
Certain Directors | 42,400 |  |  | August 26, 2022 |  | $ | 28.66 |  |  | 12 months
A summary of the status of the Company’s outstanding restricted stock is presented below:
| Fiscal Year Ended June 30, 2023
| Shares |  | Weighted-Average Grant Date Fair Value
Outstanding, beginning of year | 639,342 |  |  | $ | 32.04 |
Granted during the period | 518,987 |  |  | 28.58 |
Vested during the period | (224,062) |  |  | 30.56 |
Cancelled, forfeited, or expired during the period | (44,357) |  |  | 31.29 |
Outstanding, end of year | 889,910 |  |  | $ | 30.43 |

X
- Definition Tabular disclosure of share-based payment arrangement. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 1 -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-1 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the changes in outstanding nonvested shares. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(2) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of option exercise prices, by grouped ranges, including the upper and lower limits of the price range, the number of shares under option, weighted average exercise price and remaining contractual option terms. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(1) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (d) -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (e) -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Subparagraph (f)(2) -Name Accounting Standards Codification -Paragraph 2 -Section 50 -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Disclosure of the number and weighted-average grant date fair value for restricted stock and restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock and restricted stock units that were granted, vested, or forfeited during the year. + References No definition available. + Details
Name: | us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_ShareBasedCompensationAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration